Skip to main content

Table 4 Effects of L-carnitine supplementation on cardiac parameters

From: Effects of L-carnitine supplementation on nutritional, immunological, and cardiac parameters in hemodialysis patients: a pilot study

Variables Before 6 months
Systolic blood pressure (mmHg) 156.6 ± 3.4 155.0 ± 2.9
Diastolic blood pressure (mmHg) 76.6 ± 3.2 73.4 ± 2.9
Antihypertensive medication   
 Diuretics (%) 23.8 19.0
 α-blocker (%) 4.8 4.8
 β-blocker (%) 23.8 23.8
 Calcium antagonist (%) 42.9 42.9
 Angiotensin II type 1 receptor blocker (%) 47.6 52.4
M-mode echocardiography   
 EF (%) 69.1 ± 10.8 69.8 ± 10.5
 FS (%) 42.2 ± 11.4 46.1 ± 9.8**
 LVDd (cm) 4.5 ± 0.9 4.6 ± 0.8
 LVDs (cm) 2.6 ± 0.9 2.5 ± 0.8
 IVS (mm) 14 ± 3 15 ± 3
 LVPW (cm) 1.4 ± 0.2 1.3 ± 0.3
 LVM (g) 308.2 ± 131.1 303.5 ± 104.4
 LVMI (g/m2) 217.8 ± 100.2 212.3 ± 77.3
Chest X-ray   
 CTR (%) 52.8 ± 5.3 52.4 ± 5.0
Laboratory data   
 BNP (pg/mL) 621.4 ± 666.8 412.0 ± 426.0*
  1. EF ejection fraction, FS fractional shortening, LVDd left ventricular end-diastolic dimension, LVDs left ventricular end-systolic dimension, IVS interventricular septal thickness, LVPW left ventricular posterior wall end-diastolic thickness, LVFS left ventricular fractional shortening, LVM left ventricular mass, LVMI left ventricular mass index, CTR cardiothoracic ratio, BNP: brain natriuretic peptide, SD standard deviation
  2. *p < 0.05, **p < 0.01 vs. before treatment. Data, means ± SD